Skip to main content Skip to main navigation menu Skip to site footer

Clinical profile of patients with pseudoexfoliation glaucoma in Bali Mandara Eye Hospital from January to December 2022: a descriptive retrospective Study


Background: Pseudoexfoliative glaucoma (PEX glaucoma) is a type of secondary either open or closed-angle glaucoma that is characterized by the accumulation of flaky, whitish material on the surface of the eye. This material, known as pseudoexfoliative material (PEX), can clog the eye's drainage system, leading to increased intraocular pressure and eventual optic nerve damage if left untreated. This study aimed to describe the characteristic and management of PEXG in the Bali Mandara Eye Hospital Denpasar.

Methods: A descriptive retrospective study was conducted in March-April 2023 using electronic medical records of PEXG patients in the Bali Mandara Eye Hospital Denpasar from January–December 2022.

Results: There were 26 patients (37 eyes) diagnosed as PEXG; most of them were male (88.4%), aged 60-69 years old (34.4%), and followed by those in the range of age 70–79 years old (42.3%). Most of the cases were bilateral (59.5%) with a decrease of visual acuity of less than 3/60 (54%), an increase of intraocular pressure (IOP) with the majority in the range of 20-29 mmHg (35.1%), and 10-19 mmHg (29.8%), and followed by those who have a history of metabolic disease with Hypertension found on ten patients (38.4%) and Diabetes Mellitus on three patients (11.5%). The treatment combined several types of antiglaucoma medication and glaucoma surgery with patients who had undergone surgery in 19 eyes (51.3%). And the  post-operative visual acuity was measured and showed the most favorable results, with normal eyes found in 14 eyes  (73.6%).

Conclusion: PEX Glaucoma is commonly found in elderly patients. At the same time, most patients come with high IOP and late stage of the disease. The most frequent treatment is triple procedure surgery which produces a significant visual acuity improvement.


  1. Jeng BH. Pseudoexfoliation syndrome: a systemic disease with ocular manifestations. J Clin Exp Ophthalmol. 2014;5(6):355.
  2. Allingham RR. Shields’ textbook of glaucoma. 6th ed. North Carolina: Lippincott Williams & Wilkins; 2005.
  3. Topouzis F, Wilson MR, Harris A, et al. Prevalence of open-angle glaucoma in Greece: the Thessaloniki Eye Study. Am J Ophthalmol. 2007;144(4):511-519.
  4. Forsman E, Cantor LB, Luu K, et al. The prevalence and treatment of pseudoexfoliation among Medicare beneficiaries. Ophthalmic Surg Lasers Imaging. 2007;38(4):332-342.
  5. Jonasson F, Damji KF, Arnarsson A, et al. Prevalence of open-angle glaucoma in Iceland: Reykjavik Eye Study. Eye (Lond). 2003;17(6):747-753.
  6. Saccà SC, Gandolfi S, Bagnis A, et al. From DNA damage to functional changes of the trabecular meshwork in aging and glaucoma. Ageing Res Rev. 2016;29:26-41.
  7. Kuchtey J, Olson LM, Rinkoski T, et al. Mapping of the disease locus and identification of ADAMTS10 as a candidate gene in a canine model of primary open angle glaucoma. PLoS Genet. 2011;7(2):e1001306.
  8. Luciano L, Rejdak R, Turska M, et al. Pseudoexfoliation syndrome, vascular risk factors, and their association with age-related macular degeneration: a case-control study. Graefes Arch Clin Exp Ophthalmol. 2016;254(6):1095-1103.
  9. Konstas AG, Ritch R. Pseudoexfoliative syndrome and exfoliative glaucoma. Am J Ophthalmol. 1993;116(4):495-500.
  10. Schlötzer-Schrehardt U, Naumann GO. Ocular and systemic pseudoexfoliation syndrome. Am J Ophthalmol. 2006;141(5):921-937.
  11. Koliakos GG, Konstas AG, Schlötzer-Schrehardt U, et al. Endothelin-1 concentration is increased in the aqueous humour of patients with exfoliation syndrome. Br J Ophthalmol. 2004;88(4):523-527.
  12. Quaranta L, Katsanos A, Russo A, Riva I. 24-hour intraocular pressure and ocular perfusion pressure characteristics in exfoliative and primary open-angle glaucoma. J Glaucoma. 2014;23(5):296-302.
  13. Ringvold A, Blika S, Elsas T, et al. Pseudoexfoliation and factors related to the development of glaucoma. Acta Ophthalmol Scand. 2000;78(6):649-658.
  14. Ritch R, Schlötzer-Schrehardt U, Konstas AG. Why is glaucoma associated with exfoliation syndrome? Prog Retin Eye Res. 2003;22(3):253-275.
  15. Young AL, Tang WWT, Lam DSC. The prevalence of pseudoexfoliation syndrome in Chinese people. Br J Ophthalmol. 2004;88(2):193–5.
  16. Iqra HH, Yuwana KT, Satyarsa AB, Suryathi NM. Prevalensi dan hubungan faktor terkait tajam penglihatan pada masyarakat Desa Ngis, Karangasem, Bali tahun 2017. Intisari Sains Medis. 2020;11(2):470-5.
  17. Jeng SM, Karger RA, Hodge DO, Burke JP, Johnson DH, Good MS. The risk of glaucoma in pseudoexfoliation syndrome. J Glaucoma. 2007;16(1):117-121.

How to Cite

Natan, P. C., Yinvill, & Rahayu, N. K. . (2023). Clinical profile of patients with pseudoexfoliation glaucoma in Bali Mandara Eye Hospital from January to December 2022: a descriptive retrospective Study. Intisari Sains Medis, 14(2), 515–518.




Search Panel

Priscilla Christina Natan
Google Scholar
ISM Journal

Google Scholar
ISM Journal

Ni Kompyang Rahayu
Google Scholar
ISM Journal